loadpatents
name:-0.035181999206543
name:-0.021808862686157
name:-0.00051593780517578
SERRERO; Ginette Patent Filings

SERRERO; Ginette

Patent Applications and Registrations

Patent applications and USPTO patent grants for SERRERO; Ginette.The latest application filed is for "monoclonal antibodies and conjugates against prostaglandin f2 receptor inhibitor and uses thereof".

Company Profile
0.21.27
  • SERRERO; Ginette - Ellicott City MD
  • SERRERO; Ginette - Columbia MD
  • Serrero; Ginette - Baltimore MD
  • Serrero; Ginette - Lake Placid NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Monoclonal Antibodies And Conjugates Against Prostaglandin F2 Receptor Inhibitor And Uses Thereof
App 20210188972 - SERRERO; Ginette
2021-06-24
Methods For Diagnosing Cancer And Determining The Overall Survival And Disease-free Survival Of Cancer Patients
App 20160274114 - SERRERO; Ginette
2016-09-22
Methods and compositions for inhibiting the growth of hematopoietic malignant cells
Grant 8,911,950 - Serrero December 16, 2
2014-12-16
88kDa tumorigenic growth factor and antagonists
Grant 8,512,960 - Serrero August 20, 2
2013-08-20
Methods And Compositions For Inhibiting The Growth Of Hematopoietic Malignant Cells
App 20120087918 - Serrero; Ginette
2012-04-12
Autocrine growth factor receptor antibodies and methods
Grant 8,088,373 - Serrero , et al. January 3, 2
2012-01-03
Methods For Diagnosing Cancer And Determining The Overall Survival And Disease-free Survival Of Cancer Patients
App 20110223623 - Serrero; Ginette
2011-09-15
Methods and compositions for inhibiting the growth of hematopoietic malignant cells
Grant 8,007,997 - Serrero August 30, 2
2011-08-30
Diagnosis Of Pre-cancerous Conditions Using Pcdgf Agents
App 20110053182 - KINCH; MICHAEL S. ;   et al.
2011-03-03
Compositions and methods for restoring sensitivity to treatment with HER2 antagonists
Grant 7,815,906 - Serrero October 19, 2
2010-10-19
Methods and kits for diagnosis tumorgenicity
App 20100111928 - Serrero; Ginette
2010-05-06
Compositions and methods for restoring sensitivity to treatment with HER2 antagonists
Grant 7,674,460 - Serrero March 9, 2
2010-03-09
Methods And Compositions For Inhibiting The Growth Of Hematopoietic Malignant Cells
App 20100021475 - SERRERO; GINETTE
2010-01-28
Methods for increasing the proliferation of B cells
Grant 7,651,854 - Serrero January 26, 2
2010-01-26
88kDa tumorigenic growth factor and antagonists
Grant 7,592,318 - Serrero September 22, 2
2009-09-22
88kDa tumorigenic growth factor and antagonists
App 20090203047 - Serrero; Ginette
2009-08-13
Cancer specific monoclonal antibodies
Grant 7,560,095 - Sun , et al. July 14, 2
2009-07-14
Compositions And Methods For Restoring Sensitivity To Treatment With Her2 Antagonists
App 20090010931 - Serrero; Ginette
2009-01-08
Autocrine Growth Factor Receptor Antibodies And Methods
App 20080311120 - Serrero; Ginette ;   et al.
2008-12-18
Autocrine growth factor receptor antibodies and methods
Grant 7,411,045 - Serrero , et al. August 12, 2
2008-08-12
Autocrine Growth Factor Receptors and Methods
App 20080145369 - Serrero; Ginette
2008-06-19
Compositions And Methods For Restoring Sensitivity Of Tumor Cells To Antitumor Therapy And Inducing Apoptosis
App 20080114070 - Serrero; Ginette
2008-05-15
Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis
Grant 7,368,428 - Serrero May 6, 2
2008-05-06
Monoclonal antibody 7H11 reactive with human cancer
Grant 7,183,384 - Sun , et al. February 27, 2
2007-02-27
Cancer specific monoclonal antibodies
App 20070025911 - Sun; Le ;   et al.
2007-02-01
Methods for increasing the proliferation of B cells
App 20070015225 - SERRERO; Ginette
2007-01-18
Methods and compositions for cancer treatment
App 20060210568 - Serrero; Ginette
2006-09-21
Methods and kits for diagnosing tumorigenicity
Grant 7,091,047 - Serrero August 15, 2
2006-08-15
Compositions and methods for restoring sensitivity to treatment with HER2 antagonists
App 20050106150 - Serrero, Ginette
2005-05-19
Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy
Grant 6,881,548 - Serrero April 19, 2
2005-04-19
Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis
App 20050042225 - Serrero, Ginette
2005-02-24
Monoclonal antibody 7H11 reactive with human cancer
App 20040265930 - Sun, Le ;   et al.
2004-12-30
88kDa tumorigenic growth factor and antagonists
Grant 6,824,775 - Serrero November 30, 2
2004-11-30
88kDa tumorigenic growth factor and antagonists
App 20040131618 - Serrero, Ginette
2004-07-08
88KDA tumorigenic growth factor and antagonists
Grant 6,720,159 - Serrero April 13, 2
2004-04-13
88kDa tumorigenic growth factor and antagonists
Grant 6,670,183 - Serrero December 30, 2
2003-12-30
Methods and compositions for inhibiting the growth of hematopoietic malignant cells
App 20030215445 - Serrero, Ginette
2003-11-20
Methods and kits for diagnosing tumorigenicity
App 20030108950 - Serrero, Ginette
2003-06-12
Autocrine growth factor receptor antibodies and methods
App 20030099646 - Serrero, Ginette ;   et al.
2003-05-29
88kDa tumorigenic growth factor and antagonists
App 20030092661 - Serrero, Ginette
2003-05-15
88kDa tumorigenic growth factor and antagonists
App 20020183270 - Serrero, Ginette
2002-12-05
88kDa tumorigenic growth factor and antagonists
App 20020094966 - Serrero, Ginette
2002-07-18
88kDa tumorigenic growth factor and antagonists
App 20020061859 - Serrero, Ginette
2002-05-23
Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy
App 20020025543 - Serrero, Ginette
2002-02-28
Mammalian adipogenic factors
Grant 5,449,757 - Serrero September 12, 1
1995-09-12
Mammalian adipocyte protein p154, nucleic acids coding therefor and uses thereof
Grant 5,268,295 - Serrero December 7, 1
1993-12-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed